Share

March 03, 2020; 94 (9) Resident & Fellow Section

Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage

Jessica Rice, Randall Woltjer, Nicholas Stienstra, Elizabeth Sun, Vijayshree Yadav
First published February 10, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009047
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
828

Share

Article Information

vol. 94 no. 9 e992-e995
DOI: 
https://doi.org/10.1212/WNL.0000000000009047
PubMed: 
32041724
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 10, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Jessica Rice, MD,
    2. Randall Woltjer, MD, PhD,
    3. Nicholas Stienstra, MD,
    4. Elizabeth Sun, MD and
    5. Vijayshree Yadav, MD
  1. Jessica Rice, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Greenwich Pharmaceutical payment for travel to a consulting meeting

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Greenwich Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Randall Woltjer, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. TL4GM118965 (Carlos Crespo) NIH/NIGMS 09/26/2014-06/30/2019 “Enhancing cross disciplinary infrastructure and training at Oregon (EXITO) training” goal is to enhance ongoing undergraduate training programs that engage traditionally underrepresented students and institutions that have been unable to take part in NIH training programs. Role: Mentor R01 AG056712 (Lisa Silbert and Randall Woltjer) 04/01/18-03/31/2023 NIH/National Institute on Aging “White matter hyperintensity-associated astrocytopathy in Alzheimer’s disease and vacular cognitive impairment: a targeted histopathologic study using postmortem 7T MRI” The aim is to identify pathologic findings in MRI-associated lesions identified by postmortem imaging of elderly subjects who have been longitudinally assessed in the Alzheimer’s Disease Center at OHSU, focusing specifically on white matter disease and associated glial changes. Role: Co-PI P30 AG08017 (Jeffrey Kaye) 04/01/15-03/31/20 NIH/National Institute on Aging “Oregon Alzheimer’s Disease Center: Neuropathology Core” Role: Leader of the Neuropathology Core; as such my duties include autopsy supervision and performance with collection, organization, and distribution of brain tissue, facilitation of the use of this tissue for research purposes, pathologic diagnosis of neurodegenerative disease, presentation of case materials to clinicians, teaching residents and clinical fellows, medical students, and laboratory personnel, and development of innovative approaches to the use of the resources of the Core.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Nicholas Stienstra, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Elizabeth Sun, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Vijayshree Yadav, MD
    6. Scientific Advisory Boards:

    1. (1) Alexion (2) Celgene

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant - Celgene Advisory meeting Consultant - Alexion Advisory meeting

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Department of Veterans Affairs, 3427, Primary Investigator, 4 (2) Patient Centered Outcomes Research Institute, site PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National MS Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Oregon Health & Science University, Portland.
  1. Correspondence
    Dr. Rice ricejes{at}ohsu.edu
View Full Text

Article usage

Article usage: February 2020 to February 2023

AbstractFullPdfSource
Feb 20202101152Highwire
Mar 2020111011199Highwire
Apr 2020112833Highwire
May 2020110831Highwire
Jun 202006315Highwire
Jul 2020116423Highwire
Aug 202023716Highwire
Sep 202004723Highwire
Oct 202002212Highwire
Nov 202013824Highwire
Dec 20202277Highwire
Jan 202102410Highwire
Feb 202133021Highwire
Mar 202124517Highwire
Apr 202133624Highwire
May 202113816Highwire
Jun 20211339Highwire
Jul 202112412Highwire
Aug 202124311Highwire
Sep 202101711Highwire
Oct 202104132Highwire
Nov 202114025Highwire
Dec 20210406Highwire
Jan 20221167Highwire
Feb 20221286Highwire
Mar 20221178Highwire
Apr 20221249Highwire
May 20221198Highwire
Jun 20220133Highwire
Jul 20220144Highwire
Aug 20221147Highwire
Sep 202211518Highwire
Oct 202201210Highwire
Nov 20221209Highwire
Dec 2022182Highwire
Jan 20230188Highwire
Feb 20231160Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles